These 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys?

President Donald Trump's macroeconomic policies are taking center stage on Wall Street. The 47th U.S. president has decided to implement aggressive tariffs on imported goods from most countries, although he recently paused these plans for 90 days. Regardless, corporations are looking for ways to avoid paying these tariffs.That includes two pharmaceutical leaders: Johnson & Johnson (JNJ -0.28%) and Novartis (NVS 0.95%). The industry has so far escaped Trump's tariffs, but that might not last for much longer, ...